Top

Osteoporosis International

Published in:

01-03-2010 | Original Article

Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial

Authors: N. Yuksel, S. R. Majumdar, C. Biggs, R. T. Tsuyuki

Published in: Osteoporosis International | Issue 3/2010

Abstract

Summary

This study evaluated the effect of a multifaceted intervention (screening and patient education) by community pharmacists on testing or treatment of osteoporosis. One hundred and twenty-nine patients randomized to receive the intervention were compared to 133 patients who did not receive the intervention. Twice as many patients who got the intervention received further testing or treatment for osteoporosis.

Introduction

The objective of this study was to determine the effect of a community pharmacist screening program on testing and treatment of osteoporosis.

Methods

In this randomized, controlled trial, 262 patients meeting bone mineral density (BMD) testing guidelines [men or women aged ≥ 65 years or 50–64 years with one major risk factor including previous fracture, family history of osteoporosis, glucocorticoids for > 3 months, or early menopause] were allocated to intervention (129) or control (133). Intervention consisted of printed materials, education, and quantitative ultrasound. Primary outcome was a composite endpoint of BMD or prescription for osteoporosis medication within 4 months.

Results

Primary endpoint of BMD or osteoporosis treatment was achieved by 28 intervention patients (22%) compared with 14 controls (11%) (RR 2.1, 95% CI 1.1–3.7). This was driven by BMD testing (28 (22%) vs. 13 (10%) for controls, p = 0.011). Calcium intake increased more among intervention patients than controls (30% vs. 19%, RR 1.6, 95% CI 1.0–2.5). There was no effect on knowledge or quality of life.

Conclusion

A pharmacist screening program doubled the number of patients tested for osteoporosis. Nevertheless, many patients eligible for BMD did not receive appropriate care suggesting more intensive interventions are needed.

Brown JP, Josse RG (2002) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167(10 suppl):S1–S34PubMed

Papadimitopoulos EA (1997) Current and projected rates of hip fracture in Canada. CMAJ 157(10):1357–1363

Cummings SR, Kelsey JL, Nevitt M, O’Dowd K (1985) Epidemiology of osteoporosis and osteoporotic fracture. Epidemiol Rev 7:178–208PubMed

Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am J Med 103:12S–17SCrossRefPubMed

Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, Berger ML, Santora AC, Sherwood LM (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the National Osteoporosis Risk Assessment. JAMA 286:2815–2822CrossRefPubMed

Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA (2000) Treatment of osteoporosis: are physicians missing an opportunity? J Bone Jt Surg Am 82:1063–1070

Gallagher TC, Gerling O, Comite F (2002) Missed opportunities for prevention of osteoporotic fracture. Arch Intern Med 162:450–456CrossRefPubMed

Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz GH (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052–2057CrossRefPubMed

Hutchison BG, Abelson J, Woodward CA, Norman G (1996) Preventive care and barriers to effective prevention; how do family physicians see it. Can Fam Physician 42:1693–1700PubMed

10.

Mazanec D (2004) Osteoporosis screening: time to take responsibility. Arch Intern Med 164:1047–1048CrossRefPubMed

11.

Lafata JE, Kolk D, Peterson EL, McCarthy BD, Weiss TW, Chen YT, Muma BK (2007) Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 22:346–351CrossRefPubMed

12.

Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, Arnold M, Gauthier S, Avorn J (2007) Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 22:1808–1815CrossRefPubMed

13.

Curtis JR, Westfall AO, Allison AO, Becker A, Melton ME, Feeman A, Keife CI, MacArthur M, Ockershausen T, Stewart E, Weissman G, Saag KG (2007) Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users. Arch Intern Med 167:591–596CrossRefPubMed

14.

Solomon DH, Polinski JM, Stedman M, Truppo C, Breiner L, Egan C, Jan S, Patel M, Weiss TW, Chen YT, Brookhart MA (2007) Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 22:362–367CrossRefPubMed

15.

Solomon DH, Finkelstein JS, Pollinski JM, Arnold M, Licari A, Cabral D, Canning C, Avorn J, Katz JN (2006) A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporosis Int 17:760–67CrossRef

16.

Ciardulli LM (2003) Using health observances to promote wellness in community pharmacies. J Am Pharm Assoc 43(1):61–68CrossRef

17.

Holdford D, Kennedy DT, Bernadella P, Small R (1998) Implementing disease management in community pharmacy practice. Clin Ther 20(2):328–339CrossRefPubMed

18.

Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Taylor JG (2002) A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 162:1149–1155CrossRefPubMed

19.

Park JJ, Kelly P, Carter BL, Burgess PP (1996) Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc 36:443–451

20.

Pauley TR, Magee MJ, Curry JD (1995) Pharmacist-managed, physician directed asthma management program reduces emergency department visits. Ann Pharmacother 29:5–9PubMed

21.

Hatoum JT, Akhras K (1993) A 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother 27:1106–1119PubMed

22.

Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT (2006) Design of a randomized trial of a community pharmacist-initiated screening and intervention program for osteoporosis—The OsteoPharm Study. CPJ 139(2):50–51

23.

National Committee for Quality Assurance (NCQA). HEDIS 2004. http://www.ncqa.org/Portals/0/HEDISQM/Archives/2004/HEDIS04Update_Final.pdf. Accessed March 20, 2008

24.

Ailinger RL, Emerson J (1998) Women’s knowledge of osteoporosis. Appl Nurs Res 11(3):111–114CrossRefPubMed

25.

Ware J Jr, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 29:602–608

26.

Lydick E, Zimmerman SI, Yawn B, Love B, Kleerekoper M, Ross P, Martin A, Holmes R (1997) Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL). J Bone Miner Res 12(3):456–463CrossRefPubMed

27.

Elliott ME, Meek PD, Knaus NL, Schill GR, Weinswig PA, Bohlman JP, Zimpel CL, Jensen BC, Walters DR, Sutters SL, Peterson AN, Peterson RM, Binkley NC (2002) Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother 36:571–577CrossRefPubMed

28.

Naunton M, Peterson GR, Jones G (2006) Pharmacist-provided quantitative heel ultrasound for rural women at risk of osteoporosis. Ann Pharmacother 40:38–44PubMed

29.

Goode JV, Swiger K, Blumi BM (2004) Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from project ImPACT: osteoporosis. J Am Pharm Assoc 44(2):152–160CrossRef

30.

Bauer DC, Gluer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study, Study of Osteoporotic Fractures Research Group. Arch Intern Med 157:629–634CrossRefPubMed

31.

Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO (1996) Ultrasonographic heel measurements to predict hip fractures in elderly women: the EPIDOS prospective study. Lancet 348:511–514CrossRefPubMed

32.

Dehart RM, Gonzalez EH (2005) Osteoporosis: point of care testing. Ann Pharmacother 38:473–481

33.

Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, Maksymovich WP, Steiner IP, Harley CH, Wirzba BJ, Hanley DA, Blitz S, Russell AS (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Annals Intern Med 141:366–373

34.

Majumdar SR, Johnson JA, McAlister FA, Bellerose D, Russel AS, Hanley DA, Morrish DW, Maksymovich WP, Rowe BH (2008) Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 178(5):569–575PubMed

35.

Brooke RH, McGlynn EA, Cleary PD (1996) Quality of health care. Part 2: measurement quality of care. N Eng J Med 335:966–969CrossRef

36.

Bliuc D, Ong CR, Eisman JA, Center JR (2005) Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporosis Int 16(8):977–982CrossRef

37.

Teng GG, Warriner A, Curtis JR, Saag KG (2008) Improving quality of care in osteoporosis: opportunities and challenges. Curr Rheumatol Rep 10(2):123–130CrossRefPubMed

Title: Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial
Authors: N. Yuksel
S. R. Majumdar
C. Biggs
R. T. Tsuyuki
Publication date: 01-03-2010
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 3/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-009-0977-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial

Abstract

Summary

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2010

The relationship between low bone mass and metabolic syndrome in Korean women

High bone turnover in Irish professional jockeys

Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006

Laboratory reproducibility of biochemical markers of bone turnover in clinical practice

Height loss in elderly women is preceded by osteoporosis and is associated with digestive problems and urinary incontinence

Osteonecrosis of the jaw induced by oral administration of bisphosphonates in Asian population: five cases